Our Science

The Belfer Institute Mission

The mission of the Belfer Institute for Applied Cancer Science is to integrate academic, industry and clinical resources/expertise to enhance success in oncology drug discovery.

There are nearly 12 million people in the U.S. living with cancer and half of all men and one-third of all women in the U.S. will develop cancer in their lifetimes. While cancer therapies are improving and some cancers can now be treated effectively, there still remains a critical unmet medical need for safe and effective treatments. We believe that the next generation of cancer therapies will be identified out of emerging cancer genomics research and our goal is to help develop revolutionary new therapies that target specific molecular aberrations and attack cancer’s root causes. 

In the News

Video Commentary From Dr. Pasi Janne on New Lung Cancer Study at ASCO 2012

read more >

Study reports first success of targeted therapy in most common genetic subtype of non-small cell lung cancer

read more >

Dana-Farber's Belfer Institute for Applied Cancer Science to Present at AACR Special Conference Molecular Targeted Therapies: Mechanisms of Resistance

read more >